GIANT BIOGENE HOLDING CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.15 HKD | +2.21% |
|
+0.95% | +49.30% |
| 04-30 | Giant Biogene’s Profit Up 47% in 2023 | MT |
| 03-25 | Giant Biogene Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Giant Biogene Holding Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
0bb82b64f19cdc4909eab.lJ0jwNsDRV7kr0UnagP2YxOIiNrDkwF6MT67AtGMy3o.3fZagrB0C2qx7ipfK2iuBX3D7ffw6msZYESNerLGrT2m6RKO6FY0NorMKg~61252d12ba19126b4fa8a800edd5cd9e
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
53.15
HKD
Average target price
54.75
HKD
Spread / Average Target
+3.02%
High Price Target
59.1
HKD
Spread / Highest target
+11.19%
Low Price Target
52
HKD
Spread / Lowest Target
-2.16%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 2367 Stock
- Consensus Giant Biogene Holding Co., Ltd.
